Hsueh Yu-Wen, Yeh Tzu-Lin, Lin Chien-Yu, Tsai Szu-Ying, Liu Shu-Jung, Lin Chi-Min, Chen Hsin-Hao
Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan.
Department of Family Medicine, Hsinchu MacKay Memorial Hospital, Hsinchu, Taiwan.
PeerJ. 2020 Mar 26;8:e8815. doi: 10.7717/peerj.8815. eCollection 2020.
Metabolically healthy obesity (MHO) is defined as obesity with less than two parameters of metabolic abnormalities. Some studies report that MHO individuals show similar risk of cardiovascular disease (CVD) compared with metabolically healthy non-obese (MHNO) individuals, but the results are conflicting. Coronary artery calcium (CAC) reflects the extent of coronary atherosclerosis and is a useful tool to predict future risk of CVD. The objective of this meta-analysis was to investigate whether MHO is associated with elevated risk of CAC.
We searched Cochrane, PubMed, and Embase up to April 19, 2019. Prospective cohort and cross-sectional studies examining the association between MHO subjects and CAC were included with MHNO as the reference. Pooled odds ratio (OR) and 95% confidence interval (CI) were calculated using random-effect models. Subgroup analysis and meta-regression were applied to define possible sources of heterogeneity. We conducted this research following a pre-established protocol registered on PROSPERO (CRD 42019135006).
A total of nine studies were included in this review and six studies with 23,543 participants were eligible for the meta-analysis. Compared with MHNO subjects, MHO had a higher odds of CAC (OR 1.36, 95% CI [1.11 to 1.66]; = 39%). In the subgroup analysis, the risk associated with MHO participants was significant in cohort studies (OR = 1.47, 95% CI [1.15,1.87], = 0%), and borderline significant in cross-sectional studies. The risk of CAC was also significant in MHO participants defined by Adult Treatment Panel III (ATP III) (OR = 1.55, 95% CI [1.25,1.93], = 0%). The univariate meta-regression model showed that age and smoking status were possible effect modifiers for MHO and CAC risk.
Our meta-analysis showed that MHO phenotypes were associated with elevated risk of CAC compared with MHNO, which reflects the extent of coronary atherosclerosis. People with obesity should strive to achieve normal weight even when only one metabolic abnormality is present.
代谢健康型肥胖(MHO)被定义为代谢异常参数少于两项的肥胖。一些研究报告称,与代谢健康的非肥胖(MHNO)个体相比,MHO个体患心血管疾病(CVD)的风险相似,但结果相互矛盾。冠状动脉钙化(CAC)反映冠状动脉粥样硬化的程度,是预测未来CVD风险的有用工具。本荟萃分析的目的是研究MHO是否与CAC风险升高相关。
我们检索了截至2019年4月19日的Cochrane、PubMed和Embase数据库。纳入了以前瞻性队列研究和横断面研究来检验MHO受试者与CAC之间的关联,并以MHNO作为对照。使用随机效应模型计算合并比值比(OR)和95%置信区间(CI)。采用亚组分析和Meta回归来确定异质性的可能来源。我们按照在PROSPERO(注册号CRD 42019135006)上预先制定的方案进行了这项研究。
本综述共纳入9项研究,其中6项研究的23543名参与者符合荟萃分析的条件。与MHNO受试者相比,MHO患CAC的几率更高(OR 1.36,95%CI[1.11至1.66];P = 39%)。在亚组分析中,队列研究中MHO参与者的相关风险显著(OR = 1.47,95%CI[1.15,1.87],P = 0%),横断面研究中接近显著。根据成人治疗小组III(ATP III)定义的MHO参与者中,CAC风险也显著(OR = 1.55,95%CI[1.25,1.93],P = 0%)。单变量Meta回归模型显示,年龄和吸烟状况可能是MHO与CAC风险的效应修饰因素。
我们的荟萃分析表明,与MHNO相比,MHO表型与CAC风险升高相关,这反映了冠状动脉粥样硬化的程度。肥胖者即使仅存在一种代谢异常,也应努力实现体重正常。